Advisor Partners II’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Advisor Partners II’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$98.5K	Buy	+10,433	New	+$126K	﹤0.01%	1232

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Advisor Partners II's CDMO Position: Q3 2023 in Review

Advisor Partners II opened a new position in Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2023: 10,433 shares worth $98.5K. The stake represents ﹤0.01% of the portfolio and ranks #1232 among its holdings.

170 funds tracked by Wall St. Rank hold CDMO as of Q3 2023.

Advisor Partners II held 10,433 shares of Avid Bioservices, Inc. Common Stock worth $98.5K as of Q3 2023.
Avid Bioservices, Inc. Common Stock was a new Advisor Partners II position in Q3 2023.
Avid Bioservices, Inc. Common Stock made up ﹤0.01% of Advisor Partners II's portfolio in Q3 2023, its #1232 holding.
170 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.